ID

25661

Description

Study ID: 101468/228 Clinical Study ID: 101468/228 Study Title:A two year Phase IIIb randomised, multicenter, double-blind, SINEMET controlled, parallel group, flexible dose study, to assess the effectiveness of controlled release ropinirole add-on therapy to L-dopa at increasing the time to onset of dyskinesia in Parkinson's disease subjects. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00363727 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Dyskinesias; Parkinson Disease; Parkinson's Disease. Study part: Randomization/Drug dispensing

Keywords

  1. 8/12/17 8/12/17 -
  2. 8/12/17 8/12/17 -
  3. 8/12/17 8/12/17 -
  4. 9/8/17 9/8/17 -
Uploaded on

September 8, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


No comments

In order to download data models you must be logged in. Please log in or register for free.

Randomization/Drug dispensing GSK study Dyskinesia in Parkinson's disease NCT00363727

Randomization/Drug dispensing study Dyskinesia in Parkinson's disease NCT00363727

General information
Description

General information

Protocol identifier
Description

Protocol identifier

Data type

integer

Alias
UMLS CUI [1]
C2826693
Subject Identifier
Description

Subject Identifier

Data type

text

Alias
UMLS CUI [1]
C2348585
Visit date
Description

Visit date

Data type

date

Alias
UMLS CUI [1]
C1320303
Visit Description
Description

Visit Description

Data type

text

Alias
UMLS CUI [1,1]
C0545082
UMLS CUI [1,2]
C0678257
Total Daily L-Dopa Dosing
Description

Total Daily L-Dopa Dosing

Enter the subject's entry Total Daily L-Dopa dose
Description

Total Daily L-Dopa Dosing

Data type

integer

Measurement units
  • mg
Alias
UMLS CUI [1,1]
C0023570
UMLS CUI [1,2]
C2348070
mg
Randomization number
Description

Randomization number

Record randomisation number
Description

Randomization number

Data type

integer

Alias
UMLS CUI [1]
C2986235
Date of randomization
Description

Date of randomization

Data type

date

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C0011008
Drug dispensing
Description

Drug dispensing

Dispensing
Description

Dispense investigational product Record dispensing information in the lnvestigational Product and Compliance sections at the next visit.

Data type

text

Alias
UMLS CUI [1]
C3469597

Similar models

Randomization/Drug dispensing study Dyskinesia in Parkinson's disease NCT00363727

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
General information
Protocol identifier
Item
Protocol identifier
integer
C2826693 (UMLS CUI [1])
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Visit date
Item
Visit date
date
C1320303 (UMLS CUI [1])
Visit Description
Item
Visit Description
text
C0545082 (UMLS CUI [1,1])
C0678257 (UMLS CUI [1,2])
Item Group
Total Daily L-Dopa Dosing
Total Daily L-Dopa Dosing
Item
Enter the subject's entry Total Daily L-Dopa dose
integer
C0023570 (UMLS CUI [1,1])
C2348070 (UMLS CUI [1,2])
Item Group
Randomization number
Randomization number
Item
Record randomisation number
integer
C2986235 (UMLS CUI [1])
Date of randomization
Item
Date of randomization
date
C0034656 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
Drug dispensing
Drug Dispensing
Item
Dispensing
text
C3469597 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial